NCT05866757 - Discontinuation Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions

Multiple MyelomaCancerHematologic Cancer

Interventions

OTHER

Discontinuation of maintenance treatment

The discontinuation of maintenance treatment in multiple myeloma. Classed as interventional due to treatment being taken away.

Trial Locations (1)

RECRUITING

Cork University Hospital, Cork